Last updated: February 7, 2023
Sponsor: University Hospital, Lille
Overall Status: Active - Recruiting
Phase
N/A
Condition
Periodontitis
Treatment
N/AClinical Study ID
NCT04634201
2019_14
2020-A02179-30
Ages 12-16 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- adolescents aged 12 to 16 benefiting from social security coverage
- in good general health in brushing and taking treatments
- Have FODs
- who consent to the study and whose parents have given their consent
- suitable for orthodontic treatment in view of his oral state
Exclusion
Exclusion Criteria:
- inability to obtain informed consent
- use of another probiotic or toothpaste / antiseptic mouthwash ≤ 1 month beforeinclusion
- allergy or hypersensibiliity to the active substance or to any of the excipientslisted in the Gum® PerioBalance® user guide)
- no history of antibiotic therapy, antiseptic mouthwash ≤ 1 month before inclusion
- medical contraindication (immunosuppression, pathology requiring prophylacticantibiotic therapy before dental care)
- physiological, pathological condition, medication or behavior that may haverepercussions on the oral cavity (eg: pregnancy, diabetes, antiepileptics, tobacco)
- oral state requiring other priority care (untreated cavities, untreated activeperiodontitis, progressive recession)
Study Design
Total Participants: 116
Study Start date:
March 23, 2022
Estimated Completion Date:
March 31, 2024
Connect with a study center
Hop Salengro - Chu Lille
Lille, 59037
FranceActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.